account_id none on file
legal_name Kazia Therapeutics Ltd
ticker KZIA
cik 1075880
domain kaziatherapeutics.com
linkedin_company_url https://www.linkedin.com/company/kaziatx/
entry_point_account_id none on file
name Kazia Therapeutics Limited
exchange Nasdaq
sector Health Care
hq Sydney Nsw, Australia
sector index/company/sector/health-care/
calls 0 filings 5 executives 2 family 0
why_nownone on file
callsnone on file
filings
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, sustain profitability or commercialize our product candidates.
filing / Nov 7, 2025 / receipt
In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures.
filing / Nov 7, 2025 / receipt
The study is expected to enroll up to 76 patients with PI3K pathway mutations and will be a multicenter study at several Australian sites, with the potential to expand internationally.
filing / Nov 7, 2025 / receipt
Bryce Carmine | Non-executive Director | 2015 | Nov-26
filing / Nov 7, 2025 / receipt
Steven Coffey | Non-executive Director | 2012 | Nov-25
filing / Nov 7, 2025 / receipt
executives
| Bryce Carmine | Non-executive Director | - | receipt |
| Steven Coffey | Non-executive Director | - | receipt |
familynone on file
upcoming
| 2026-11-06 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug kazia-therapeutics-limited
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$